St. Michael's Hospital
Toronto, Ontario, M5B 1M8, Canada
Location status: Recruiting
Location contact
Molly Hyde, MSc, PhD (cand.)
CONTACT
416-864-6060 ext. 7844
Sakina Rizvi, PhD, RP
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05613972
The investigators have developed a novel suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate the specific impacts of childhood trauma on suicide risk. The aim of this pilot is to test 12-weeks of ISTT to alleviate suicide risk among individuals with a history of childhood trauma and current suicidality.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Toronto, Ontario, M5B 1M8, Canada
Location status: Recruiting
Molly Hyde, MSc, PhD (cand.)
CONTACT
416-864-6060 ext. 7844
Sakina Rizvi, PhD, RP
PRINCIPAL_INVESTIGATOR
In the last 10 years, despite available treatments, suicide rates have not significantly decreased, and individuals who have experienced any type of childhood maltreatment are at increased odds for suicide attempt. Effective suicide prevention requires learning skills to cope with suicidality in addition to addressing the antecedent factors that contribute to suicide risk. In the context of those with childhood trauma and suicidality, addressing antecedent factors may require treatments that target symptoms associated with developmental trauma. Thus, the investigators have developed an integrated suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate the specific impacts of childhood trauma on suicide risk. The aim of this pilot is to test 12-weeks of BSTT to alleviate suicide risk among individuals with a history of childhood trauma and current suicidality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12-week trauma therapy for suicide risk
Time frame: From baseline to 1 week post-therapy
Beck Scale for Suicide Ideation is a 21-item self-report scale that quantifies suicidal ideation. Items are scored 0 to 2 and yield a total score ranging from 0 to 38. Higher scores reflect greater severity of suicidal ideation.
Time frame: From baseline to 1 week post-therapy
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), Feasibility of Intervention Measure (FIM), in addition to a feedback survey and interview created in-house with questions designed to collect quantitative and qualitative feedback from participants with respect to the feasibility and acceptability of the BSTT intervention.
Time frame: From baseline to 1-week post therapy
The GAD-7 is a brief 7-item self-report scale measuring anxiety symptoms. Total scores range from 0 to 21, with higher scores reflecting more severe anxiety.
Time frame: From baseline to 1 week post-therapy
The QIDS is a 16-item validated depression scale. Total scores range from 0-27, with higher scores reflecting more severe depression.
Time frame: From baseline to 1 week post-therapy
The DERS is a 36-item validated scale measuring six aspects of emotion regulation. The DERS is comprised of 6 subscales, where higher scores are reflective of greater difficulties in emotion regulation. The DERS is often analyzed by percentile.
Contact information is provided by the study sponsor or research team.
Aleksandra Lalovic, PhD,MEd,RP
CONTACT
416-864-6060 ext. 46483
Sakina Rizvi, PhD,MACP,RP
CONTACT
416-864-6060 ext. 6489
Unity Health Toronto
Other
Using Integrated Suicide and Trauma Therapy to Reduce Suicide Risk Among Adults With a History of Childhood Trauma
Acronym: ISTT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06462196
Analgesics, Anesthetics
Bethesda, Maryland, United States
View Trial DetailsNCT05437588
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT06480500
Behavior, Behavioral Symptoms
Toronto, Ontario, Canada
View Trial DetailsNCT05317481
Behavior, Behavioral Symptoms
New Haven, Connecticut, United States
View Trial Details